It’s A First (And Second) For IPF: Two Drugs Approved By FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approved the first two drugs for the fatal lung disease idiopathic pulmonary fibrosis: Roche’s Esbriet and Boehringer Ingelheim’s Ofev. The simultaneous approvals set the stage for a commercial showdown.